June 18, 2014

There’s a lot happening in the allergy space right now. Chattem’s Nasacort Allergy 24HR recently hit store shelves, and in a little more than 10 weeks on the shelf the nasal corticosteroid has already generated $33.6 million in sales across total U.S. multi-outlets, according to IRI.

April 21, 2014

McNeil Consumer Healthcare recently introduced a new form to the Zyrtec portfolio of allergy-relief products — an oral, dissolvable tablet.

March 6, 2014

McNeil Consumer Healthcare on Wednesday introduced a new form to the Zyrtec portfolio of allergy-relief products — an oral, dissolvable tablet.

September 10, 2013

Perrigo announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for cetirizine hydrochloride oral solution USP, 1 mg/mL, bubble gum flavored, the store brand equivalent to Children's Zyrtec Allergy Syrup.

June 4, 2013

Johnson & Johnson division McNeil Consumer Healthcare has launched a new marketing campaign around the allergy medication Zyrtec, according to published reports.

April 6, 2012

McNeil Consumer Healthcare, the maker of Zyrtec, on Wednesday announced that actress Kate Walsh and beauty expert Rebekah George will address "allergy face" — the beauty challenges that can come along with typical allergy symptoms — during a live webcast April 10 at 8 p.m. EST on Ustream, a live interactive broadcast platform.

February 17, 2012

Clarinex (desloratadine), the next-generation prescription allergy remedy to the second-generation Claritin, is 1-of-3 blockbuster prescription medicines that may make the crossover from prescription-only to over-the-counter in the near future.

June 20, 2011

In the year leading up to the switch of Allegra, Sanofi generated $214.2 million in U.S. prescription sales of Allegra, largely due to the generic competition against its Allegra D formulation. Now Sanofi is looking to virtually match those annual sales figures within the much more profitable nonprescription venue with the company’s successful switch from prescription to OTC this spring. 


May 24, 2011

The Food and Drug Administration has approved a generic over-the-counter treatment for allergies made by Taro Pharmaceutical Industries.

April 25, 2011

Customers are seeing purple again — reminiscent of another switch that took advantage of the eye-catching color purple. Sanofi-Aventis through its Chattem division in March launched Allegra, the last of the second-generation antihistamines. And purple-powered displays, like this in a Walmart in Lancaster, Pa., dotted the retail pharmacy landscape.


March 30, 2011

Prestige Brands on Wednesday announced the launch of a new one-dose-per-day allergy medicine — PediaCare 24-hour allergy.

March 29, 2011

Indian generic drug maker Dr. Reddy’s Labs has launched a generic treatment for seasonal allergies, the company said Tuesday.

March 7, 2011

An over-the-counter version of the antihistamine Allegra hit the marketplace amid a promotional frenzy that was consistent with the approach taken when such similar products as Claritin and Zyrtec became available without a prescription. As was the case with other products before it, retailers are eager to get their share of sales, so there tends to be considerable activity around the launch.

March 4, 2011

As Drug Store News suggested last month, legislation under consideration in Tennessee and Kentucky that would make the popular decongestant pseudoephedrine only available by prescription has, in fact, sparked interest in neighboring states.

February 18, 2011

All the hype around H1N1 
that was so prevalent in 2009 is gone, leaving only the tough comparisons a year later.

November 30, 2010

The Food and Drug Administration has granted market exclusivity for a generic version of a medication designed to treat indoor and outdoor allergies.

May 16, 2010

As of Feb. 9, Sanofi-Aventis officially entered the self-care solution arena with its acquisition of...

March 21, 2010

"The Biggest Loser" and "Days of Our Lives" star Alison Sweeney will join McNeil Consumer...

June 28, 2009

There was speculation in January that Schering-Plough’s switch application around the proton-pump inhibitor Zegerid was...

February 28, 2009

Despite all the debate over the use of cough-cold medicines in children under the age of 12, sales of cough-cold medicines didn’t do too badly last year. For the 52 weeks ended Jan. 25, sales of all cough-cold remedies — including cough drops, cough syrups, cold-allergy liquids and cold-allergy tablets — were up 10.5%, totaling $4 billion across food, drug and mass outlets (minus Walmart) according to Information Resources Inc data. Of course, the lion’s share of that growth comes courtesy of the latest allergy reliever to make its way from prescription vials to over-the-counter aisles. Factoring out the sales impact of McNeil Consumer Healthcare’s Zyrtec, which generated in excess of $331 million across its Zyrtec syrup, Zyrtec tablet and Zyrtec-D tablet, the overall cough-cold category still grew by 1.4%. Considering that’s on a base of $3.6 billion, that represents incremental growth of almost $50 million.